A product’s Intended Use, Indications for Use, and Mechanism of Action (MOA) are the foundation of its regulatory classification—determining whether it will be regulated as a medical device, pharmaceutical, or consumer product.
Even subtle changes in claims can significantly impact how a product is regulated.
A product's Intended Use, Indication for Use, and Mechanism of Action (MOA) are critical factors that determine its regulatory classification—whether as a medical device, pharmaceutical, or consumer product.
For example, a crib mattress with an innovative design might initially be classified as a consumer product. However, if claims are made that the mattress reduces the risk of Sudden Infant Death Syndrome (SIDS) by encouraging infants to sleep on their backs, the product could fall under medical device regulations.
Clearly defining these elements early in development not only shapes your product's regulatory pathway but also helps avoid costly missteps and delays in bringing your product to market.
Your product’s technology—and how it achieves its intended purpose—plays a central role in determining how it is regulated.
Depending on how it interacts with the human body, your product may be classified as a:
This classification is not always consistent globally. A product considered a medical device in the EU or UK may be regulated as a drug in the United States.
The key differentiator is how the product achieves its effect—whether through physical, chemical, or biological means. Clearly understanding and articulating this is essential to navigating global regulatory pathways efficiently and avoiding unnecessary complications.
RQMIS ensures your product definition and regulatory strategy are aligned from the beginning—so you can move forward with clarity and confidence.
Our services include:
We integrate your product definition, development strategy, and regulatory pathway into a cohesive plan, setting the stage for efficient approvals and successful market entry.